Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viaderma Inc (VDRM)

Viaderma Inc (VDRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 0.01
  • Price/Book 0.00
Trade VDRM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0080 +56.25%
on 03/18/24
0.0150 -16.67%
on 03/22/24
+0.0025 (+25.00%)
since 02/28/24
3-Month
0.0080 +56.25%
on 03/18/24
0.0150 -16.67%
on 03/22/24
+0.0010 (+8.70%)
since 12/28/23
52-Week
0.0080 +56.25%
on 03/18/24
0.0299 -58.19%
on 03/29/23
-0.0170 (-57.63%)
since 03/28/23

Most Recent Stories

More News
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products

The Company’s improved, new Vitastem products have recently begun large scale production...

VDRM : 0.0125 (-3.85%)
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year

Revenues increased by over 4000% in 2021, while liabilities decreased by more than 25%...

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Files Amended Financial Statements

LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website reporting...

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Provides Updates on Current Business Activities

The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates

Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12 million contract

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network

LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter

The Company realized significant Q1 revenue growth due to increased online retail sales and proceeds from a licensing agreement

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Announces the Payment of all Toxic Convertible Notes and Has Become Debt Free

The Company expects to completely self-fund all operations going forward

VDRM : 0.0125 (-3.85%)
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States

LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices....

VDRM : 0.0125 (-3.85%)
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021

LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,   (“Company”)   (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his expectations...

VDRM : 0.0125 (-3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.0163
2nd Resistance Point 0.0149
1st Resistance Point 0.0139
Last Price 0.0125
1st Support Level 0.0115
2nd Support Level 0.0101
3rd Support Level 0.0091

See More

52-Week High 0.0299
Fibonacci 61.8% 0.0215
Fibonacci 50% 0.0190
Fibonacci 38.2% 0.0164
Last Price 0.0125
52-Week Low 0.0080

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar